You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Ovarian cancer

Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer

  • Technology appraisal guidance
  • Reference number: TA284
  • Published:  22 May 2013
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Information for the public

  • Bevacizumab with paclitaxel and carboplatin as first-line treatment for advanced ovarian cancer (PDF 180 KB)

    Published:
    22 May 2013
  • Gwybodaeth i'r cyhoedd (Word 92 KB)

    Published:
    07 October 2013